Results 211 to 220 of about 15,263 (254)

Comparison of Dupilumab and Revision Endoscopic Sinus Surgery for Recurrent Chronic Rhinosinusitis with Nasal Polyps: A Retrospective Cohort Study. [PDF]

J Clin Med
Kamiński B, Ochab D, Flaga S, Łacwik P, Jasikowska M, Pałczyński C.   +5 more
europepmc   +1 more source

Evidence Summary of Pruritus Management in Patients With Atopic Dermatitis: Implications for Nursing Practice

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background To synthesize the most current and relevant evidence regarding pruritus management in patients with atopic dermatitis (AD), and to identify implications for nursing assessment, education, monitoring, and follow‐up. Method An extensive literature search was conducted across multiple databases, including the Cochrane Library, Embase ...
Yuzhen Shen, Qian Shen, Manni Chen, Rufang Liu   +3 more
wiley   +1 more source

Drug‐Induced Vitiligo: FDA Adverse Events Reporting System (FAERS) and Canada Vigilance Adverse Reaction (CAVR) Database Analysis and Literature Review

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Vitiligo is a common chronic acquired pigmentation disease, that usually occurs with an asymptomatic whitish patch or macule. Although previous studies have reported several cases of drug‐induced vitiligo, there are few comprehensive studies determining the drugs that induce vitiligo.
Yuhao Li, Yi Ou, Luyue Chang, Ruiyao Wang, Xinyi Shao, Jingbo Zhang, Jin Chen   +6 more
wiley   +1 more source

Dupilumab and ritlecitinib combination therapy in a patient with alopecia totalis and atopic disease. [PDF]

JAAD Case Rep
Zappi I, Spindler A, Maas D, Orlow SJ, Shapiro J, Lo Sicco KI.   +5 more
europepmc   +1 more source

Targeting type 2 inflammation in dermatology: mechanisms and clinical implications. [PDF]

Front Immunol
Khalil N, Farhadi L, Yosipovitch G.
europepmc   +1 more source

Spotlight July–September 2026: What's New in JEADV—Editor‐in‐Chief's Selection

JEADV Clinical Practice, Volume 5, Issue 3, Page 763-768, September 2026.
Carle Paul
wiley   +1 more source

Critical flaws in: "Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study". [PDF]

Eur Respir J
Bacharier LB, Busse WW, Jackson DJ, Katial RK.   +3 more
europepmc   +1 more source

High degree of remission in pediatric severe asthma patients treated with biologics in a real-world setting. [PDF]

World Allergy Organ J
Cerda Reyes S, Larenas-Linnemann D, Castillón Benavides NK.   +2 more
europepmc   +1 more source

Efficacy and Safety of Dupilumab in Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis.

Int Arch Allergy Immunol
Khalaf R, Ton That A, Tardio N, Afif W, Schneider R, Ben-Shoshan M.   +5 more
europepmc   +1 more source

Case Report: Dupilumab-associated ulcerative colitis: elucidating the pathomechanistic link between Th2 blockade and Th17 polarized intestinal inflammation. [PDF]

Front Immunol
Fu F, Zhao Q, Ma L, Wang A, Wang Z, Xu X.   +5 more
europepmc   +1 more source